Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life.

Francesco Menzella,Matteo Fontana,Marco Contoli,Patrizia Ruggiero,Carla Galeone,Silvia Capobelli,Anna Simonazzi,Chiara Catellani,Chiara Scelfo,Claudia Castagnetti,Francesco Livrieri,Nicola Facciolongo

Journal of asthma and allergy（2022）

引用 6|浏览3

暂无评分

摘要

Our study, the longest clinical follow-up on patients treated with anti-IgE, confirms and amplifies the results of the studies carried out so far, as they are maintained over a very long interval of time without drops in efficacy without any type of side effect.

查看译文

关键词

biologics,exacerbations,omalizumab,oral corticosteroids,severe allergic asthma,side effects

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要